Frédéric Triebel
Technik-/Wissenschafts-/F&E-Leiter bei IMMUTEP LIMITED
Vermögen: 2 Mio $ am 30.04.2024
Aktive Positionen von Frédéric Triebel
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| IMMUTEP LIMITED | Direktor/Vorstandsmitglied | 13.09.2022 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 12.12.2014 | - | |
Immutep SAS
 Immutep SAS Pharmaceuticals: MajorHealth Technology Immutep SAS specializes in biotechnology research and development. It develops immunotherapy treatments for cancer and autoimmune diseases. The company was founded by Frédéric Triebel on October 17, 2001 and is headquartered Orsay, France. | Vorstandsvorsitzender | 14.07.2016 | - |
| Gründer | 01.01.2001 | - | |
| Direktor/Vorstandsmitglied | 01.01.2001 | 18.11.2015 | |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2001 | - |
Karriereverlauf von Frédéric Triebel
Ehemalige bekannte Positionen von Frédéric Triebel
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Direktor/Vorstandsmitglied | 01.01.1991 | 01.01.1996 |
| Université de Paris IV Paris-Sorbonne | Corporate Officer/Principal | - | - |
IGREC SASU
 IGREC SASU Miscellaneous Commercial ServicesCommercial Services IGREC SASU provides accounting services. It offers concepts of recovery before maturity, detection, classification and handling of disputes, and the concepts of sustainable improvement of payment delays and customer satisfaction. The company was founded in 1993 and is headquartered in Caraman, France. | Corporate Officer/Principal | - | - |
Ausbildung von Frédéric Triebel
| Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
Statistik
International
| Frankreich | 6 |
| Australien | 2 |
Operativ
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IMMUTEP LIMITED | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Commercial Services |
| Université de Paris IV Paris-Sorbonne | Consumer Services |
IGREC SASU
IGREC SASU Miscellaneous Commercial ServicesCommercial Services IGREC SASU provides accounting services. It offers concepts of recovery before maturity, detection, classification and handling of disputes, and the concepts of sustainable improvement of payment delays and customer satisfaction. The company was founded in 1993 and is headquartered in Caraman, France. | Commercial Services |
Immutep SAS
Immutep SAS Pharmaceuticals: MajorHealth Technology Immutep SAS specializes in biotechnology research and development. It develops immunotherapy treatments for cancer and autoimmune diseases. The company was founded by Frédéric Triebel on October 17, 2001 and is headquartered Orsay, France. | Health Technology |
- Börse
- Insiders
- Frédéric Triebel
- Erfahrung
